TROP2 타깃 프로그램 | 바이오모아

Data Tier

ADC · Antibody · CGT를 FDA 승인, ORR·PASI·ACR·BCVA, 임상 등록 규모, Phase 3, 조회수 등 공개 데이터로 복합 점수화합니다. S–C 티어와 가점 요인은 규칙 기반(Data Tier)이며 LLM이 아닙니다.

RSS 구독 차세대 추천

이 조건에 티어를 산출할 프로그램이 없습니다.

프로그램 (7)

ADCBiologicstaleMerck Sharp & Dohme LLCPhase 2

H1: TROP2 ADC (H1: TROP2 ADC)

Triple-negative Breast Cancer · TROP2

#TROP2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 3상태 RECRUITING

ADCBiologicstaleFudan UniversityPhase 2

B2: TROP2 ADC with Camrelizumab (B2: TROP2 ADC with Camrelizumab)

Triple-negative Breast Cancer · TROP2

#TROP2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 1상태 RECRUITING

ADCBiologicstaleFudan UniversityPhase 2

D2: TROP2 ADC with BP102 (D2: TROP2 ADC with BP102)

Triple-negative Breast Cancer · TROP2

#TROP2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 1상태 RECRUITING

ADCBiologicstaleFudan UniversityPhase 2

F1: TROP2 ADC (F1: TROP2 ADC)

Triple-negative Breast Cancer · TROP2

#TROP2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 1상태 RECRUITING

CGTBiologicstaleM.D. Anderson Cancer CenterPhase 1

TGFBR2 KO iC9/TROP2.CAR/IL-15 NK cells (TGFBR2 KO iC9/TROP2.CAR/IL-15 NK cells)

Breast Cancer · TROP2

#TROP2#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 1상태 RECRUITING

CGTBiologicstaleHenan Cancer HospitalPhase 2

Anti-Trop2 CAR-NK cell (Anti-Trop2 CAR-NK cell)

Non-Small Cell Lung Cancer NSCLC · TROP2

#TROP2#CGT#Phase2#세포유전치료#CAR-T+3

임상시험 1상태 RECRUITING

CGTBiologicstaleBellicum Pharmaceuticals, Inc.Phase 1

TROP2-CAR-NK Cells (TROP2-CAR-NK Cells)

Colorectal Cancer; Minimal Residual Disease · TROP2

#TROP2#CGT#Phase1#세포유전치료#CAR-T+4

임상시험 1상태 RECRUITING